STOCK TITAN

Insider at Company (NASDAQ: IONS) plans 85,089-share stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of common stock has filed a Form 144 notice to sell 85,089 shares through Stifel Nicolaus & Company on the Nasdaq market. The filing lists an aggregate market value of $7,056,227 for this planned sale, with 161,974,393 shares outstanding for the issuer.

The seller, identified as Frank Bennett, acquired 65,089 shares via an option exercise dated 01/03/2022 and 20,000 shares through restricted stock units dated 01/15/2017. In the past three months, he has already sold 5,885 and 8,977 shares of common stock for gross proceeds of $487,898 and $684,264, respectively.

Positive

  • None.

Negative

  • None.

Insights

Form 144 pre-discloses a sizable insider share sale but within a routine regulatory framework.

The notice shows Frank Bennett planning to sell 85,089 shares of common stock through Stifel Nicolaus & Company on Nasdaq, with an aggregate market value of $7,056,227. The issuer has 161,974,393 shares outstanding, providing scale for the planned transaction.

Shares to be sold were acquired via a stock option exercise dated 01/03/2022 (65,089 shares, cash payment) and restricted stock units granted on 01/15/2017 (20,000 shares as equity compensation). Over the prior three months, Bennett sold 5,885 and 8,977 shares, generating gross proceeds of $487,898 and $684,264.

Because this is a disclosure of intended sales under Rule 144, it functions as transparency into potential insider selling activity rather than a change in the company’s operations. Actual impact depends on market conditions and execution of these planned trades.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the IONS Form 144 filing disclose?

The Form 144 discloses that Frank Bennett plans to sell 85,089 shares of common stock through Stifel Nicolaus on Nasdaq, with an aggregate market value of about $7.06 million and issuer shares outstanding of 161,974,393.

How many IONS shares is the insider planning to sell under Form 144?

The filing shows a planned sale of 85,089 shares of common stock. These shares are to be sold through Stifel Nicolaus & Company on Nasdaq, with an aggregate stated market value of approximately $7,056,227 at the time of the notice.

What is the recent selling history for the IONS insider in this Form 144?

Over the past three months, Frank Bennett sold 5,885 shares on 01/30/2026 and 8,977 shares on 01/16/2026. These transactions produced gross proceeds of $487,898 and $684,264, respectively, according to the disclosure.

How were the IONS shares in the Form 144 originally acquired?

The Form 144 states that 65,089 shares were acquired via an option exercise dated 01/03/2022, paid in cash, and 20,000 shares were acquired as restricted stock units granted on 01/15/2017 as equity compensation from the issuer.

What does the Form 144 say about IONS shares outstanding?

The filing reports that the issuer has 161,974,393 shares of common stock outstanding. This figure provides context for the planned sale of 85,089 shares, helping investors gauge the relative scale of the disclosed insider transaction.

When is the IONS insider planning to execute the Form 144 sale?

The approximate date of sale listed is 02/02/2026. On or around this date, the Form 144 indicates that 85,089 shares of common stock may be sold on the Nasdaq market through broker Stifel Nicolaus & Company.
Ionis Pharmaceuticals

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Latest SEC Filings

IONS Stock Data

13.70B
160.61M
0.65%
108.48%
6.59%
Biotechnology
Pharmaceutical Preparations
Link
United States
CARLSBAD